Immunoglobulins in Primary Progressive and Relapsing-Remitting Multiple Sclerosis
September 28th 2023Jason Freeman, MD, MBA, and Shankar Sadasivan, PhD, discuss the poster “Immunoglobulins in Primary Progressive and Relapsing-Remitting Multiple Sclerosis” presented at ACTRIMS 2023. Sponsored By Novartis.
Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis
September 25th 2023Jason Freeman, MD, MBA, and Brandon Brown, PharmD, discuss the poster “Five-Year Safety of Ofatumumab in People Living with Relapsing Multiple Sclerosis” presented at AAN 2023. Sponsored By Novartis.
How Well Do You Know COPAXONE® (glatiramer acetate injection)?
October 22nd 2021This year, Teva is celebrating the 25th anniversary of the FDA approval of COPAXONE® (glatiramer acetate injection), but the story goes back much further. Hear what some of Teva's most prominent R&D leaders have to say about the history and origins of the treatment.